COLGATE PALMOLIVE CO(CL)— Stock Profile, AI Score & Financials
Consumer Staples · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
COLGATE PALMOLIVE CO (CL) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores CL at 61.3/100 on a 32-signal composite quality model, placing it at rank #788 of 2,960 stocks — the top half of the AI-ranked universe. CL scores in the top quartile across revenue scale (92.8), balance sheet strength (88.8). Areas of concern include revenue growth (34.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), COLGATE PALMOLIVE CO reports quarterly revenue of $5.4B, net income of $693.0M, an operating margin of 18.9%. Top institutional holders of CL by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. CL trades on the NYSE exchange and files with the SEC under CIK 21665. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COLGATE PALMOLIVE CO directly from SEC EDGAR.
AI Quality Score
61.3/100
AI Rank
#788
Revenue
$5.4B
Net Income
$693.0M
Free Cash Flow
$867.0M
Operating Margin
18.9%
CL key financials by period
COLGATE PALMOLIVE CO reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$20.4B
$2.1B
16.2%
FY 2024
10-K
$20.1B
$2.9B
21.2%
FY 2023
10-K
$19.5B
$2.3B
20.5%
FY 2022
10-K
$18.0B
$1.8B
16.1%
FY 2021
10-K
$17.4B
$2.2B
19.1%
FY 2020
10-K
$16.5B
$2.7B
23.6%
Institutions holding CL
Institutional investors reporting a position in COLGATE PALMOLIVE CO on SEC Form 13F.
AI-extracted from the 10-Q filed 2026-07-31 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Net sales rose 4.9% to $5,361M on 2.4% organic growth, but $129M of Strategic Growth and Productivity Program charges cut operating profit 6% to $1,016M.
Biggest Revenue Drivers
Latin America (Oral, Personal and Home Care)$1,372M+13.7% YoY
Volume growth of 2.6%, net selling price increases of 2.8% and positive foreign exchange of 8.4%; organic growth led by Mexico, Brazil and Argentina.
Hill's Pet Nutrition$1,195M+3.4% YoY
Net selling price increases of 3.9% and positive foreign exchange of 0.6%, partially offset by volume declines of 1.2%; growth in therapeutic and wellness categories.
Biggest Revenue Drivers
Total revenue: $5,361M+4.9% YoY
Latin America (Oral, Personal and Home Care)$1,372M+13.7% YoY
Volume growth of 2.6%, net selling price increases of 2.8% and positive foreign exchange of 8.4%; organic growth led by Mexico, Brazil and Argentina.
Hill's Pet Nutrition$1,195M+3.4% YoY
Net selling price increases of 3.9% and positive foreign exchange of 0.6%, partially offset by volume declines of 1.2%; growth in therapeutic and wellness categories.
Europe, Middle East & Africa (Oral, Personal and Home Care)$1,121M+3.5% YoY
Volume growth of 3.2% and positive foreign exchange of 1.6%, partially offset by net selling price decreases of 1.2%; led by Türkiye, Germany, UK and Italy.
North America (Oral, Personal and Home Care)$891M-3.0% YoY
Volume declines of 3.9% partially offset by net selling price increases of 0.9%; decline driven by the United States, mainly toothpaste, bar soap and body wash.
Asia Pacific (Oral, Personal and Home Care)$782M+4.9% YoY
Volume growth of 4.1% and net selling price increases of 1.1%; organic growth driven by India, the Greater China region and the Philippines.
Largest Expense Items
Selling, general and administrative expenses$2,130M+9% YoY
Increased advertising investment of $99 and higher overhead expenses of $60; advertising rose to 14.5% of net sales from 13.3%.
Cost of sales$2,065Mvs. $2,041M prior-year quarter
Gross margin gained from funding-the-growth savings (280 bps), partly offset by higher raw and packaging material costs (220 bps) including tariff impacts.
Other (income) expense, net$150Mvs. $26M prior-year quarter
Included $120 of charges resulting from the Strategic Growth and Productivity Program; excluding these, $30 versus $17 a year ago.
Margins: Gross profit margin rose 140 bps to 61.5%, driven by funding-the-growth savings (280 bps), pricing (60 bps) and mix (20 bps), offset by higher raw and packaging costs (220 bps). GAAP operating margin fell 210 bps to 19.0% on restructuring charges.
Watch Items from the Filing
Strategic Growth and Productivity Program cost $129 pre-tax this quarter; cumulative pre-tax charges are estimated at $350 to $550 through December 31, 2028.
North America net sales fell 3.0% to $891 on volume declines of 3.9%; management expects category softness to continue through the second half of 2026.
Talcum powder cases pending rose to 525 at June 30, 2026 from 484 at March 31 and 453 at December 31, 2025; 84 new cases filed this quarter.
Aggregate reasonably possible losses in excess of accrued liabilities estimated at $0 to approximately $225, plus Brazilian tax assessments of roughly $105 and $28.
Approximately two-thirds of net sales are outside the United States and roughly 45% from emerging markets, with acute FX volatility in Argentina, Nigeria and Türkiye.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
